NCT05950594 2026-03-16
IVIM & OLINK in Sarcoma
University Health Network, Toronto
Phase 2 Recruiting
Clinical Trials
10 trialsNCT06660810 2026-01-15
Neoadjuvant Intralesional Injection of Talimogene Laherparepvec
University of Iowa
Phase 2 Active not recruiting
NCT06835049 2025-12-30
TNT-HYPE
Swiss Cancer Institute
Phase 2 Recruiting
NCT03896620 2025-12-24
Recognition of Circulating Tumor DNA in Soft Tissue Sarcoma
Medical College of Wisconsin
Recruiting
NCT02789384 2025-12-02
NEOSarcomics
Institut Bergonié
Phase NA Recruiting
NCT07227961 2025-11-13
PROMIS and Mobility Evaluation in Sarcoma Patients
University of Calgary
Recruiting
NCT03217266 2025-09-23
Navtemadlin and Radiation Therapy in Treating Patients With Soft Tissue Sarcoma
National Cancer Institute (NCI)
Phase 1 Completed
NCT03978039 2025-09-04
BCB-Sarcomes
Institut Bergonié
Recruiting
NCT06670976 2025-08-26
Propranolol Plus Standard Radiation Therapy Before Surgery for the Treatment of Patients With Soft Tissue Sarcoma
Roswell Park Cancer Institute
Phase 1 Withdrawn
NCT05560009 2025-07-10
An Imaging Agent (Fluorodopa F 18) With Positron Emission Tomography/Magnetic Resonance Imaging for Assessing Treatment Response in Patients With High-Grade Soft Tissue Sarcomas
Mayo Clinic
Completed